Vincent Verlant

636 total citations
16 papers, 443 citations indexed

About

Vincent Verlant is a scholar working on Epidemiology, Microbiology and Molecular Biology. According to data from OpenAlex, Vincent Verlant has authored 16 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 4 papers in Microbiology and 1 paper in Molecular Biology. Recurrent topics in Vincent Verlant's work include Pneumonia and Respiratory Infections (14 papers), Respiratory viral infections research (13 papers) and Pneumocystis jirovecii pneumonia detection and treatment (7 papers). Vincent Verlant is often cited by papers focused on Pneumonia and Respiratory Infections (14 papers), Respiratory viral infections research (13 papers) and Pneumocystis jirovecii pneumonia detection and treatment (7 papers). Vincent Verlant collaborates with scholars based in Belgium, Finland and United States. Vincent Verlant's co-authors include Jan Poolman, Philippe Denoël, Philippe Hermand, Fabrice Godfroid, Vincent Weynants, Ralph C. Judd, Michael P. Jennings, Karine Goraj, Martine P. Bos and Pierre Vandepapelière and has published in prestigious journals such as American Journal of Epidemiology, Journal of Clinical Microbiology and Infection and Immunity.

In The Last Decade

Vincent Verlant

16 papers receiving 430 citations

Peers

Countries citing papers authored by Vincent Verlant

Since Specialization

Citations

This map shows the geographic impact of Vincent Verlant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent Verlant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent Verlant more than expected).

Fields of papers citing papers by Vincent Verlant

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent Verlant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent Verlant. The network helps show where Vincent Verlant may publish in the future.

Co-authorship network of co-authors of Vincent Verlant

This figure shows the co-authorship network connecting the top 25 collaborators of Vincent Verlant. A scholar is included among the top collaborators of Vincent Verlant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent Verlant. Vincent Verlant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Immunogenicity of pneumococcal conjugate vaccine formulations containing pneumococcal proteins, and immunogenicity and reactogenicity of co-administered routine vaccines – A phase II, randomised, observer-blind study in Gambian infants 2019 ·Vaccine ·Aderonke Odutola, Martin O. C. Ota, Martín Antonio, Ezra Olatunde Ogundare, Yauba Saidu, Patrick K. Owiafe, Archibald Worwui, Olubukola T. Idoko, Olumuyiwa Owolabi, Beate Kampmann, Brian Greenwood, Mark R. Alderson, Magali Traskine, Kristien Swinnen, Vincent Verlant, Kurt Dobbelaere, Dorota Borys	20
2	Comparison between a new multiplex electrochemiluminescence assay and the WHO reference enzyme-linked immunosorbent assay to measure serum antibodies against pneumococcal serotype-specific polysaccharides 2019 ·Vaccine ·(unknown), (unknown), (unknown), Damien Friel, Estelle Merck, Vincent Verlant, (unknown), (unknown), (unknown), (unknown), (unknown), David Goldblatt, Sonia Schoonbroodt	4
3	lytA Quantitative PCR on Sputum and Nasopharyngeal Swab Samples for Detection of Pneumococcal Pneumonia among the Elderly 2018 ·STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) ·Annika Saukkoriipi, Arto A. Palmu, Thierry Pascal, Vincent Verlant, William P. Hausdorff, Jukka Jokinen	1
4	Testing Pneumonia Vaccines in the Elderly: Determining a Case Definition for Pneumococcal Pneumonia in the Absence of a Gold Standard 2017 ·American Journal of Epidemiology ·Jukka Jokinen, (unknown), Arto A. Palmu, Annika Saukkoriipi, Vincent Verlant, Thierry Pascal, Jeanne‐Marie Devaster, William P. Hausdorff, Terhi Kilpi	5
5	lytA Quantitative PCR on Sputum and Nasopharyngeal Swab Samples for Detection of Pneumococcal Pneumonia among the Elderly 2017 ·Journal of Clinical Microbiology ·Annika Saukkoriipi, Arto A. Palmu, Thierry Pascal, Vincent Verlant, William P. Hausdorff, Jukka Jokinen	10
6	Preclinical evaluation of a chemically detoxified pneumolysin as pneumococcal vaccine antigen 2016 ·Human Vaccines & Immunotherapeutics ·Philippe Hermand, A. Vandercammen, Emmanuel Mertens, Emmanuel Di Paolo, Vincent Verlant, Philippe Denoël, Fabrice Godfroid	20
7	Reactogenicity, safety and immunogenicity of a protein-based pneumococcal vaccine in Gambian children aged 2–4 years: A phase II randomized study 2015 ·Human Vaccines & Immunotherapeutics ·Aderonke Odutola, (unknown), (unknown), Martín Antonio, Patrick K. Owiafe, Archibald Worwui, Brian Greenwood, Mark R. Alderson, Magali Traskine, Vincent Verlant, Kurt Dobbelaere, Dorota Borys	33
8	Incidence and etiology of community-acquired pneumonia in the elderly in a prospective population-based study 2014 ·Scandinavian Journal of Infectious Diseases ·Arto A. Palmu, Annika Saukkoriipi, (unknown), Jukka Jokinen, (unknown), Thedi Ziegler, Tarja Kaijalainen, William P. Hausdorff, Vincent Verlant, Terhi Kilpi	20
9	Effect of antimicrobial use on pneumococcal diagnostic tests in elderly patients with community-acquired pneumonia 2014 ·European Journal of Clinical Microbiology & Infectious Diseases ·Annika Saukkoriipi, Arto A. Palmu, Janne J. Jokinen, Vincent Verlant, William P. Hausdorff, Terhi Kilpi	12
10	Randomized Controlled Study of the Safety and Immunogenicity of Pneumococcal Vaccine Formulations Containing PhtD and Detoxified Pneumolysin with Alum or Adjuvant System AS02 _V in Elderly Adults 2014 ·Clinical and Vaccine Immunology ·Karlis Pauksens, Anna Nilsson, (unknown), Thierry Pascal, Pascale Van Belle, Jan Poolman, Pierre Vandepapelière, Vincent Verlant, Peter Vink	31
11	Adjuvant system AS02V enhances humoral and cellular immune responses to pneumococcal protein PhtD vaccine in healthy young and older adults: Randomised, controlled trials 2013 ·Vaccine ·Isabel Leroux‐Roels, Jeanne‐Marie Devaster, Geert Leroux‐Roels, Vincent Verlant, Isabelle Henckaerts, Philippe Moris, Philippe Hermand, Pascale Van Belle, Jan Poolman, Pierre Vandepapelière, Yves Horsmans	52
12	Combined protective effects of anti-PhtD and anti-pneumococcal polysaccharides 2011 ·Vaccine ·Philippe Denoël, Fabrice Godfroid, Philippe Hermand, Vincent Verlant, Jan Poolman	14
13	Preclinical Evaluation of the Pht Proteins as Potential Cross-Protective Pneumococcal Vaccine Antigens 2010 ·Infection and Immunity ·Fabrice Godfroid, Philippe Hermand, Vincent Verlant, Philippe Denoël, Jan Poolman	76
14	Additive and Synergistic Bactericidal Activity of Antibodies Directed against Minor Outer Membrane Proteins of Neisseria meningitidis 2007 ·Infection and Immunity ·Vincent Weynants, Christiane Feron, Karine Goraj, Martine P. Bos, Philippe Denoël, Vincent Verlant, Jan Tommassen, Ian R. Peak, Ralph C. Judd, Michael P. Jennings, Jan Poolman	83
15	Protective Immunity against Congenital Toxoplasmosis with Recombinant SAG1 Protein in a Guinea Pig Model 2000 ·Infection and Immunity ·Michèle Haumont, (unknown), Lida Garcia, (unknown), (unknown), (unknown), Vincent Verlant, Alex Bollen, Ralph Biemans, Alain Jacquet	56
16	The tum⁻ antigens P91A and P198 derive from proteins located in the cytosolic compartment of cells 1993 ·European Journal of Immunology ·Vincent Verlant, A Amar-Costesec, Danièle Godelaine, (unknown), Aline Van Pel, Etienne De Plaen, Alice Dautry‐Varsat, Henri Beaufay	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact